Hamilton Capital Partners (Canada)’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8M Buy
62,293
+7,100
+13% +$831K 0.23% 77
2026
Q1
$6.64M Sell
55,193
-8,977
-14% -$1.04M 0.22% 72
2025
Q4
$6.75M Buy
64,170
+4,264
+7% +$400K 0.25% 72
2025
Q3
$5.03M Buy
59,906
+5,477
+10% +$451K 0.21% 85
2025
Q2
$4.31M Buy
54,429
+10,108
+23% +$803K 0.22% 90
2025
Q1
$3.98M Buy
44,321
+10,427
+31% +$974K 0.26% 84
2024
Q4
$3.37M Sell
33,894
-3,940
-10% -$406K 0.25% 84
2024
Q3
$4.3M Buy
37,834
+829
+2% +$98.5K 0.37% 71
2024
Q2
$4.58M Buy
37,005
+497
+1% +$64K 0.49% 62
2024
Q1
$4.82M Buy
+36,508
New +$4.5M 0.58% 47

Other funds holding MRK

Hamilton Capital Partners (Canada)'s MRK Position: Q2 2026 in Review

Hamilton Capital Partners (Canada) increased its Merck (MRK) stake by 13% in Q2 2026, buying an estimated $831K and bringing the position to 62,293 shares worth $8M. The position accounts for 0.23% of the portfolio, ranked #77.

Hamilton Capital Partners (Canada) first reported a position in MRK in Q1 2024 and has held it in 10 quarters since. 3,688 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Hamilton Capital Partners (Canada) held 62,293 shares of Merck worth $8M as of Q2 2026.
  • Hamilton Capital Partners (Canada) bought 7,100 Merck shares in Q2 2026, an estimated $831K.
  • Merck made up 0.23% of Hamilton Capital Partners (Canada)'s portfolio in Q2 2026, its #77 holding.
  • Hamilton Capital Partners (Canada) first reported a position in Merck in Q1 2024 and has held it in 10 quarters since.
  • 3,688 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Hamilton Capital Partners (Canada)'s 13F filing for Q2 2026, filed 14 Aug 2026.